A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups. Originally developed for diabetes,

National Resilience, a startup that has raised over $2 billion by promising to transform drug manufacturing, said Monday that it would “wind down” many of

WEIGHT loss jabs could prevent a medication taken by millions of women from working – and increase patients’ risk of cancer. The British Menopause Society

Metsera has linked its amylin analog to 8.4% placebo-adjusted weight loss at Day 36, advancing its push to develop an ultralong-acting challenger to candidates in

GLP-1 drugs “alter taste perception” and “disrupt the perception of sweetness, bitterness, fatty foods and even mouthfeel”, a study says. The post GLP-1 drugs “alter

GLP-1 drugs “alter taste perception” and “disrupt the perception of sweetness, bitterness, fatty foods and even mouthfeel”, a study says.

GLP-1 drugs are transforming medicine, but what are the medical and societal ripple effects?

Politics Most Favored Nation Drug Pricing Will Flop, but What Wouldn’t? Pursuing the worthy goal of reforming drug pricing requires a more radical change to

The 71-year-old OWN CEO finally reached her 160lb goal weight in 2023 with help from an unnamed GLP-1 agonist drug after undergoing double-knee replacement surgery

Will a telehealth model effectively engage adolescents with obesity and their parents to participate in their treatment plan? Do GLP-1 agonist medications work to improve

We’ve known that our immune system and the process of inflammation are tightly intertwined and are affected by aging. The terms immunosenescence and inflammaging have

Obesity is a major health problem facing our country.  According to the CDC, more than 40 percent of the U.S. population is obese, defined as having

CLARE Butler struggled with her weight for most of her adult life. As an emotional eater, food was her go-to whenever she felt sad, happy,

Plus, what to add to your grocery list this week

Researchers at the University of Toronto have found GLP-1 weight loss and diabetes drugs like Ozempic and Mounjaro double the risk of a severe form

FINISHING an eight-mile run, Tracy Hughes walks into her bathroom and turns on the shower. Wearing her form-fitting exercise kit, the mum-of-four has a svelte

submitted by /u/mvea [link] [comments]

(MedPage Today) — You passed medical training, now see if you can pass our weekly quiz

Post Content

(NaturalNews) Ozempic/Wegovy users risk losing muscle, bone mass and mental health as severe side effects. GLP-1 drugs linked to 62,000 adverse events and 16…

“Pharmacist Holding a Box of Ozempic” by chemist4u, CC BY 2.0 “O God, give us the serenity to accept what cannot be changed, the courage

Omada Health Shares Soar After IPO as GLP-1 Drugs Fuel Interest  WSJ Omada shares rise 21% in Nasdaq debut after health tech company’s IPO  CNBC Omada Health

The producer of Ozempic was advised to list the serious eye condition as a side effect The European Medicines Agency (EMA) has concluded that semaglutide-based

GLP-1 drugs like Ozempic could lead to a higher risk of wet age-related macular degeneration in people with type 2 diabetes. Westend61/Getty Images GLP-1 drugs

The EMA’s safety committee has issued a warning that the GLP-1 receptor agonist Ozempic (semaglutide, Novo Nordisk A/S) can cause an acute eye condition in

“I want to know I’m doing absolutely everything I can to preserve my health for as long as possible.” We hear this kind of thing

Eighty-five percent of US GLP-1 drug consumers report major changes in their food and beverage preferences after starting the medications, says a new report from

An obesity and internal medicine specialist based in New York, Dr Alexandra Sowa has been researching and practising obesity medicine for about a decade now.

FRIDAY, June 6, 2025 — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident

Novo Nordisk NVO has seen strong momentum in recent years, driven by the commercial success of its blockbuster semaglutide products, Wegovy (obesity) and Ozempic (diabetes).

The European Medicines Agency said Friday that the product information for Novo Nordisk’s Ozempic and Wegovy should be updated to list a serious eye condition

A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The weight-loss

(MedPage Today) — A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines